It's well-known that Americans pay more for healthcare and drugs than many other nations, and a recent study confirms that the trend is the same when it comes to oncology drugs.
Patently perturbed: Trans-Pacific Partnership trade deal raises fears about drug patent periods, higher costs
Multilateral trade deals—such as the Trans-Pacific Partnership touted by President Barack Obama on his recent trip through Asia—are usually of little concern or consequence to healthcare stakeholders. But the TPP could affect pharmaceutical pricing around the globe.
Game of Thrones” fans are all too familiar with the character known as the Mountain. The hulking giant is perhaps best-known for his, uh, crushing victory over Prince Oberyn Martell.
If fear of flying mortarboards figures prominently in your phobias, then the University of East Anglia is on your side.
Colombia's government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals.
French officials ruffled the feathers of foodies this month when they announced that foie gras, the luxury pâté made from the fattened duck or goose liver, would not be produced for three months.
President Obama's upcoming visit to Hiroshima in pursuit of a nuclear weapon-free world will unleash uncomfortable emotions on both sides of the Pacific. He ought to note what survivors of the blast taught mankind about the long-term effects of radiation exposure and the threat posed by nuclear war.
When the ad agency behind Rhode Island's official tourism ad slipped up and included some images from Iceland, a local oral surgeon saw an opening.
The World Health Organization—the central coordinating body for international health within the United Nations' system, which employs more than 7,000 people in 150 offices around the world—is due for a new chief executive.
The digital experience at Humber River Hospital in northwest Toronto begins the moment patients arrive. The sleek, square building feels like a small airport, with each registration area designated with a letter. Before arriving, patients look online to find out their check-in zone.
Since it came a few weeks past April Fools' Day, the announcement of an anti-aging gin appears to be on the level. The 80-proof concoction is the brainchild of Warner Leisure Hotels, a chain based in the United Kingdom. It touts Anti-aGin as the “alcoholic equivalent of a facial.”
Federal money left over from the largely successful fight against Ebola will now go to combating the growing threat of the Zika virus, the Obama administration announced Wednesday.